Objectives
To aid the development of treatment for cognitive impairment in bipolar disorder, the International Society for Bipolar Disorders (ISBD) convened a task force to create a consensus‐based ...guidance paper for the methodology and design of cognition trials in bipolar disorder.
Methods
The task force was launched in September 2016, consisting of 18 international experts from nine countries. A series of methodological issues were identified based on literature review and expert opinion. The issues were discussed and expanded upon in an initial face‐to‐face meeting, telephone conference call and email exchanges. Based upon these exchanges, recommendations were achieved.
Results
Key methodological challenges are: lack of consensus on how to screen for entry into cognitive treatment trials, define cognitive impairment, track efficacy, assess functional implications, and manage mood symptoms and concomitant medication. Task force recommendations are to: (i) enrich trials with objectively measured cognitively impaired patients; (ii) generally select a broad cognitive composite score as the primary outcome and a functional measure as a key secondary outcome; and (iii) include remitted or partly remitted patients. It is strongly encouraged that trials exclude patients with current substance or alcohol use disorders, neurological disease or unstable medical illness, and keep non‐study medications stable. Additional methodological considerations include neuroimaging assessments, targeting of treatments to illness stage and using a multimodal approach.
Conclusions
This ISBD task force guidance paper provides the first consensus‐based recommendations for cognition trials in bipolar disorder. Adherence to these recommendations will likely improve the sensitivity in detecting treatment efficacy in future trials and increase comparability between studies.
Objectives
Cognition is a new treatment target to aid functional recovery and enhance quality of life for patients with bipolar disorder. The International Society for Bipolar Disorders (ISBD) ...Targeting Cognition Task Force aimed to develop consensus‐based clinical recommendations on whether, when and how to assess and address cognitive impairment.
Methods
The task force, consisting of 19 international experts from nine countries, discussed the challenges and recommendations in a face‐to‐face meeting, telephone conference call and email exchanges. Consensus‐based recommendations were achieved through these exchanges with no need for formal consensus methods.
Results
The identified questions were: (I) Should cognitive screening assessments be routinely conducted in clinical settings? (II) What are the most feasible screening tools? (III) What are the implications if cognitive impairment is detected? (IV) What are the treatment perspectives? Key recommendations are that clinicians: (I) formally screen cognition in partially or fully remitted patients whenever possible, (II) use brief, easy‐to‐administer tools such as the Screen for Cognitive Impairment in Psychiatry and Cognitive Complaints in Bipolar Disorder Rating Assessment, and (III) evaluate the impact of medication and comorbidity, refer patients for comprehensive neuropsychological evaluation when clinically indicated, and encourage patients to build cognitive reserve. Regarding question (IV), there is limited evidence for current evidence‐based treatments but intense research efforts are underway to identify new pharmacological and/or psychological cognition treatments.
Conclusions
This task force paper provides the first consensus‐based recommendations for clinicians on whether, when, and how to assess and address cognition, which may aid patients’ functional recovery and improve their quality of life.
Disturbances of cognitive function are considered to largely affect the outcome in patients with schizophrenia. There is much attention to the role of psychotropic compounds acting on serotonin ...(5-HT) receptors in ameliorating cognitive deficits of the disease. Among the 5-HT receptor subtypes, the 5-HT(1A) receptor is attracting particular interests as a potential target for enhancing cognition, based on preclinical and clinical evidence. The neural network underlying the ability of 5-HT(1A) agonists to treat cognitive impairments of schizophrenia likely includes dopamine, glutamate, and gamma-aminobutyric acid neurons. Recent advances of electrophysiological measures, such as event-related potentials, have provided insights into facilitative effects on cognition of some atypical antipsychotic drugs or related compounds acting directly or indirectly on 5-HT(1A) receptors. These considerations are expected to promote the development of novel therapeutics for the betterment of functional outcome in people suffering from schizophrenia.
Sumiyoshi T, Uchida H, Watanabe K, et al. Neuropsychiatr Dis Treat. 2022;18:2507-2517. The authors have advised there are errors in the text and Table 1 on page 2512 of the published paper. Table 1 ...Pearson Correlation Coefficients Between WPAI Subscale Scores and PDQ-D-5 Total Scores Validity of the PDQ-D-5 by Comparison with Other Measures section, fourth sentence, the text "PDQ-D-5 scores showed a moderate correlation with the presenteeism (rmcorr, 0.56, p < 0.0001), overall work impairment (rmcorr, 0.58, p < 0.0001), and impairment of general activity (rmcorr, 0.63, p < 0.0001) subscale scores on WPAI, while the correlation with absenteeism scores was weak (rmcorr, 0.21, p < 0.004) (Table 1)" should read "PDQ-D-5 scores showed a moderate correlation with the presenteeism (rmcorr, 0.51, p < 0.0001), overall work impairment (rmcorr, 0.51, p < 0.0001), and impairment of general activity (rmcorr, 0.54, p < 0.0001) subscale scores on WPAI, while the correlation with absenteeism scores was weak (rmcorr, −0.04, p = 0.31) (Table 1)". The correct Table 1 is as follows. The authors confirm that they do not believe that the modifications detailed above affect the interpretation of the results and consider them to be numerical in nature only. The authors apologize for these errors.
We present a search for signatures of neutrino mixing of electron anti-neutrinos with additional hypothetical sterile neutrino flavors using the Double Chooz experiment. The search is based on data ...from 5 years of operation of Double Chooz, including 2 years in the two-detector configuration. The analysis is based on a profile likelihood, i.e. comparing the data to the model prediction of disappearance in a data-to-data comparison of the two respective detectors. The analysis is optimized for a model of three active and one sterile neutrino. It is sensitive in the typical mass range
5
×
10
-
3
eV
2
≲
Δ
m
41
2
≲
3
×
10
-
1
eV
2
for mixing angles down to
sin
2
2
θ
14
≳
0.02
. No significant disappearance additionally to the conventional disappearance related to
θ
13
is observed and correspondingly exclusion bounds on the sterile mixing parameter
θ
14
as a function of
Δ
m
41
2
are obtained.
Test of the HAPD light sensor for the Belle II Aerogel RICH Yusa, Y.; Adachi, I.; Dolenec, R. ...
Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment,
12/2017, Letnik:
876
Journal Article
Recenzirano
The Aerogel Ring-Imaging Cherenkov detector (ARICH) is being installed in the endcap region of Belle II spectrometer to identify particles from B meson decays by detecting the Cherenkov ring image ...from aerogel radiators. To detect single photons, high-sensitive photon detector which has wide effective area (∼70mm × 70mm), a Hybrid Avalanche Photo Detector (HAPD), has been developed in a collaboration with Hamamatsu K.K. The HAPD consists of hybrid structure of a vacuum tube and an avalanche photodiode (APD). It can be operated in 1.5T magnetic field of the spectrometer and withstands the radiation levels expected in the Belle II experiment. There are two steps of electric pulse amplification: acceleration of photo-electron in electric field in the vacuum tube part and electron avalanche in the APD part resulting in total gain of order 105. For the ARICH, we use 420 HAPDs in total. Before installing them, we performed quality assessment studies such as measurements of dark current, noise level, signal-to-noise ratio and two-dimensional scan with laser illumination. We also measured quantum efficiency of the photocathode. During the HAPD performance tests in the magnetic field, we observed very large signal pulses which cause long dead time of the readout electronics in some of the HAPDs. We have carried out a number of studies to understand this phenomenon, and have found a way to mitigate it and suppress the degradation of the ARICH performance. In this report, we will show a summary of the HAPD performance and quality assessment measurements including validation in the magnetic field for all of the HAPDs manufactured for the ARICH in the Belle II.
To validate the five-item version of the Perceived Deficits Questionnaire for Depression (PDQ-D-5) for assessing subjective cognitive function in Japanese patients with major depressive disorder ...(MDD) using data from the PERFORM-J study.
A total of 518 Japanese outpatients diagnosed with MDD were assessed on severity of depressive symptoms, cognitive function, social and work function, and quality of life (QoL) over 6 months following initiation of antidepressant therapy. This post hoc analysis evaluated the internal consistency and convergent validity of the PDQ-D-5 in relation to the original PDQ-D-20. Correlations of scores on these measures were examined at each time point and over time. The same set of analyses was explored between PDQ-D-5 and the Patient Health Questionnaire-nine-item (PHQ-9), Montgomery-Asberg Depression Rating Scale (MADRS), Digit Symbol Substitution Test (DSST), five-level version of EQ-5D (EQ-5D-5L), Sheehan Disability Scale (SDS), and Work Productivity and Activity Impairment (WPAI) questionnaire.
PDQ-D-5 scores showed good internal consistency. Strong positive correlations were observed between PDQ-D-5 and PDQ-D-20 at each time point (correlation coefficient: baseline, 0.94; month 1, 0.94; month 2, 0.96; month 6, 0.96) and over time (0.92) (all p < 0.0001). Longitudinally, there were positive correlations between PDQ-D-5 scores versus those on the PHQ-9, MADRS, and SDS. Similarly, negative correlations were noted between PDQ-D-5 scores and EQ-5D-5L and DSST scores to a variable degree. There were moderate positive correlations over time between PDQ-D-5 and all WPAI subscale scores except those on absenteeism.
PDQ-D-5 scores rated in Japanese patients with MDD were found to adequately represent scores on the PDQ-D-20. The short version also showed associations with several measures of functional outcome, depression severity and QoL. This validates the PDQ-D-5 as a feasible and clinically reliable tool to assess subjective experience on cognition, which is applicable to time-limited consultations.
UMIN000024320.
In the forward end-cap of the Belle II spectrometer, particle identification is provided by a proximity focusing RICH detector with an aerogel radiator (ARICH). The ARICH’s primary function is to ...effectively distinguish between pions and kaons in the momentum range of 0.5GeV/c to about 4GeV/c, as well as to contribute to identification of low-momentum leptons. Since its operation began, Belle II has collected over 420fb−1 of data. Based on this large data sample, studies of several effects that impact the performance of the ARICH detector were carried out. In this paper, we present a comparison of the observed Cherenkov ring image and detector particle identification performance in the measured data and detector simulation. Furthermore, we highlight recent efforts aimed at enhancing the ARICH’s performance by taking into account the effects of particle decay in flight and scattering in materials before the detector, as well as by refining the probability density function used for particle identification likelihood evaluation.
Although injuries have been linked to worse mental health, little is known about this association among the general population in low- and middle-income countries (LAMICs). This study examined the ...association between injuries and depression in 40 LAMICs that participated in the World Health Survey.
Cross-sectional information was obtained from 212 039 community-based adults on the past 12-month experience of road traffic and other (non-traffic) injuries and depression, which was assessed using questions based on the World Mental Health Survey version of the Composite International Diagnostic Interview. Multivariable logistic regression analysis and meta-analysis were used to examine associations.
The overall prevalence (95% CI) of past 12-month traffic injury, other injury, and depression was 2.8% (2.6-3.0%), 4.8% (4.6-5.0%) and 7.4% (7.1-7.8%), respectively. The prevalence of traffic injuries range 0.1% (Ethiopia) to 5.1% (Bangladesh), and other (non-traffic) injuries range 0.9% (Myanmar) to 12.1% (Kenya) varied widely across countries. After adjusting for demographic variables, alcohol consumption and smoking, the pooled OR (95%CI) for depression among individuals experiencing traffic injury based on a meta-analysis was 1.72 (1.48-1.99), and 2.04 (1.85-2.24) for those with other injuries. There was little between-country heterogeneity in the association between either form of injury and depression, although for traffic injuries, significant heterogeneity was observed between groups by country-income level (p = 0.043) where the pooled association was strongest in upper middle-income countries (OR = 2.37) and weakest in low-income countries (OR = 1.46).
Alerting health care providers in LAMICs to the increased risk of worse mental health among injury survivors and establishing effective trauma treatment systems to reduce the detrimental effects of injury should now be prioritised.